In today’s modern world, where scientific progress and medical advancements shape our understanding of health and wellness, an alarming trend has emerged. The convergence of powerful pharmaceutical companies, scholars, scientists, universities, and researchers has led to the development of disease names based solely on collections of symptoms.
Let’s shed some light on the questionable practices associated with this process and how it results in non-profit organizations raising funds for research, which can be seen as a profiteering scam that exploits innocent Americans and their hard-earned cash.
1. The Government’s Collaborative Role:
A. Government Funding:
The government plays a significant role in enabling pharmaceutical profiteering by providing substantial funding for research initiatives aimed at discovering cures for newly invented or discovered diseases. This financial support often comes without proper scrutiny, creating an environment ripe for exploitation.
B. Regulatory Leniency:
The government’s regulatory leniency towards pharmaceutical companies allows them to profit from the creation of disease names based solely on symptom collections. By enabling this practice, the government indirectly contributes to the profiteering scam, as it fails to establish stringent guidelines for disease identification and naming.
2. The Disease Naming Process:
A. Symptom Clustering:
Pharmaceutical companies, in collaboration with scholars, scientists, universities, and researchers, engage in the process of clustering symptoms to create new disease names. This approach disregards the underlying causes and complexities of various health conditions, focusing solely on symptomatology. By doing so, they create an illusion of novel diseases, which benefits their profit-driven motives.
B. Medicalization of Everyday Conditions:
Through the process of symptom clustering, everyday conditions that were previously considered within the range of normal human experiences are now transformed into medical diseases. This medicalization perpetuates the notion that individuals require treatment for natural variations in human health, ultimately driving up the demand for pharmaceutical products and subsequent profits.
3. Non-Profit Organizations and the Charade:
A: Fundraising Strategies:
Non-profit organizations, established under the guise of seeking a cure for these newly invented or discovered diseases, utilize emotionally charged fundraising campaigns. They exploit the fears and vulnerabilities of innocent Americans, urging them to contribute their hard-earned cash in the pursuit of elusive cures.
B: Minimal Accountability:
These non-profit organizations often face minimal scrutiny, allowing them to channel funds toward research initiatives that may lack proper scientific rigor. The lack of accountability raises concerns about the true intentions of these organizations and whether their activities genuinely serve the public interest or are driven primarily by financial gain.
Conclusion:
The collusion between the government, pharmaceutical companies, scholars, scientists, universities, and researchers have created a system that enables the profiteering scam of raising funds for newly invented or discovered diseases.
By developing disease names based on collections of symptoms and fostering the growth of non-profit organizations, innocent Americans are swindled out of their hard-earned cash.
It is crucial for us (our society) to question the integrity of this system, demand transparency, and advocate for responsible medical practices that prioritize genuine public health over profit-seeking motives.
